The latest financial statement is for the quarter ending 2025-09-30.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net revenue | 19,021 | - |
| Cost of goods sold | 8,350 | - |
| Variable sales costs | 8,140 | - |
| Other vendor and payroll expenses | 3,437 | - |
| Depreciation and amortization | 406 | - |
| Stock-based compensation expense | 731 | - |
| Other segment items | -238 | - |
| Net loss | -2,281 | -8,756 |
| Depreciation and amortization | 406 | 812 |
| Provision for sales returns | -40 | -49 |
| Amortization of deferred financing cost and debt discounts | 41 | 75 |
| Stock-based compensation | 731 | 905 |
| Deferred tax expense | 0 | 0 |
| Change in inventory provisions | -31 | 574 |
| Change in fair value of warrant liabilities | -18 | -90 |
| Allowance for credit losses | 0 | -147 |
| Accounts receivable | -568 | -897 |
| Inventory | -1,371 | 5,322 |
| Prepaid and other current assets | -24 | 91 |
| Accounts payable, accrued and other liabilities | -2,337 | 2,905 |
| Cash (used in) provided by operating activities | -1,566 | -8,287 |
| Purchase of fixed assets | 40 | 6 |
| Purchase of minority equity investment | 0 | 0 |
| Cash used in investing activities | -40 | -6 |
| Repayments on seller notes | 0 | 113 |
| Borrowings from midcap credit facilities | 12,752 | 23,424 |
| Repayments for midcap credit facilities | 13,805 | 23,220 |
| Insurance obligation payments | 202 | 409 |
| Insurance financing proceeds | 0 | 706 |
| Cash used in financing activities | -1,255 | 388 |
| Foreign currency effect on cash and restricted cash | -98 | 448 |
| Net change in cash and restricted cash for the period | -2,959 | -7,457 |
| Cash and cash equivalents at beginning of period | 19,143 | - |
| Cash and cash equivalents at end of period | 8,727 | - |
Aterian, Inc. (ATER)
Aterian, Inc. (ATER)